Salivary alpha-synuclein levels Parkinson’s disease and Progressive Supranuclear Palsy patients


  • Levels of different forms of salivary alpha-synuclein can distinguish people with Parkinson’s disease (PD) from Progressive Supranuclear Palsy (PSP).

Why this matters

  • Alpha-synuclein is an easily accessible biomarker which may be able to distinguish PD from PSP and correlate neurodegeneration with clinical findings.